Azoles
Medchemexpress LLC Pyridine-3,5-dicarboxylic acid | 499-81-0 | 167.12 | 50 G
Pyridine-3,5-dicarboxylic acid is a drug intermediate that can be used to construct new metal-organic framework materials. It is intended for research use only.
- Used as a drug intermediate.
- Can be used to construct new metal-organic framework materials.
- Intended for research use only.
Medchemexpress LLC Methyl 4-hydroxyphenylacetate | 14199-15-6 | 166.18 | 50 G
Methyl 4-hydroxyphenylacetate is a natural compound, a methyl ester formed by the condensation of 4-Hydroxyphenylacetic acid with methanol. It presents as a colorless to light yellow liquid with a density of 1.1708 g/cm³. This compound is classified as a phenol and monophenol, originally isolated from the mangrove-derived fungus Eupenicillium sp. HJ002.
- Natural compound and methyl ester
- Colorless to light yellow liquid appearance
- Density of 1.1708 g/cm³
- Classified as a phenol and monophenol
- Isolated from specific mangrove-derived fungus
- Intended for research use only
- Storage at 4°C under nitrogen for optimal stability
- Recommended shipping at room temperature (within continental US)
- Stock solutions stable at -80°C for up to 6 months or -20°C for 1 month under nitrogen
Accela Chembio Inc Methyl 1-methylimidazole-5-carboxylate | 5g | 17289-20-2 | MFCD01567300 | 97+% | Shelf Life: 720 Days | Light Sensitive/nitrogen Or Argon/+4
Methyl 1-methylimidazole-5-carboxylate | 5g | 17289-20-2 | MFCD01567300 | 97+% | Shelf Life: 720 Days | Light Sensitive/nitrogen Or Argon/+4
Chem-Impex International, Inc. N,N-Carbonyldiimidazole | 530-62-1 | MFCD00005286 | 5KG
N,N-Carbonyldiimidazole, 530-62-1, MFCD00005286, 5KG
Chem-Impex International, Inc. N,N-Carbonyldiimidazole | 530-62-1 | MFCD00005286 | 250G
N,N-Carbonyldiimidazole, 530-62-1, MFCD00005286, 250G
Medchemexpress LLC Β-Methyl L-aspartate hydrochloride | 16856-13-6 | MFCD00038972 | 98.0% | 183.59 | 10 G
Β-Methyl L-aspartate hydrochloride | 16856-13-6 | MFCD00038972 | 98.0% | 183.59 | 10 G
Medchemexpress LLC Carbimazole | 22232-54-8 | 98.0% | 1 G
Carbimazole is an orally active antithyroid agent that rapidly converts to Methimazole after absorption. It prevents the thyroid peroxidase enzyme from iodinating and coupling tyrosine residues on thyroglobulin, thereby reducing the production of thyroxine. Carbimazole also exhibits anti-inflammatory and neuronal-protective activities, suggesting its use for hyperthyroidism and neurological research.
- Orally active antithyroid agent
- Converts to methimazole after absorption
- Reduces thyroxine production
- Exhibits anti-inflammatory activities
- Exhibits neuronal-protective activities
eMolecules 25171-19-1 | 2,4-Dichloro-7-methylquinazoline | Combi-Blocks | MFCD11858254 | 213.060 | C9H6Cl2N2 | 98.000 | Cc1ccc2c(Cl)nc(Cl)nc2c1 | 1g | 495743410
2,4-Dichloro-7-methylquinazoline | Combi-Blocks | 25171-19-1 | MFCD11858254 | 213.060 | C9H6Cl2N2 | 98.000 | Cc1ccc2c(Cl)nc(Cl)nc2c1 | 1g | 495743410
![eMolecules 205319-06-8 | PdCl2 DPEPhos | Ambeed715.890 | C36H28Cl2OP2Pd | 98.000 | [Cl-].[Cl-].[Pd++].O(c1ccccc1P(c1ccccc1)c1ccccc1)c1ccccc1P(c1ccccc1)c1ccccc1 | 25g | 798837772](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000470191.jpg-250.jpg)
eMolecules 205319-06-8 | PdCl2 DPEPhos | Ambeed715.890 | C36H28Cl2OP2Pd | 98.000 | [Cl-].[Cl-].[Pd++].O(c1ccccc1P(c1ccccc1)c1ccccc1)c1ccccc1P(c1ccccc1)c1ccccc1 | 25g | 798837772
PdCl2 DPEPhos | Ambeed | 205319-06-8715.890 | C36H28Cl2OP2Pd | 98.000 | [Cl-].[Cl-].[Pd++].O(c1ccccc1P(c1ccccc1)c1ccccc1)c1ccccc1P(c1ccccc1)c1ccccc1 | 25g | 798837772
![eMolecules 90213-66-4 | 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine | Ochem Incorporation | MFCD08059278 | 188.010 | C6H3Cl2N3 | 97.000 | Clc1nc(Cl)c2cc[nH]c2n1 | 100g | 772463646](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000190174.jpg-250.jpg)
eMolecules 90213-66-4 | 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine | Ochem Incorporation | MFCD08059278 | 188.010 | C6H3Cl2N3 | 97.000 | Clc1nc(Cl)c2cc[nH]c2n1 | 100g | 772463646
2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine | Ochem Incorporation | 90213-66-4 | MFCD08059278 | 188.010 | C6H3Cl2N3 | 97.000 | Clc1nc(Cl)c2cc[nH]c2n1 | 100g | 772463646
eMolecules 92920-33-7 | 3,6-Dichloro-4-fluoropyridazine | Combi-Blocks, Inc. | MFCD21648467 | 166.960 | C4HCl2FN2 | 95.000 | Fc1cc(Cl)nnc1Cl | 25g | 882683289
3,6-Dichloro-4-fluoropyridazine | Combi-Blocks, Inc. | 92920-33-7 | MFCD21648467 | 166.960 | C4HCl2FN2 | 95.000 | Fc1cc(Cl)nnc1Cl | 25g | 882683289
Apexbio Technology LLC 3,3',5'-Triiodo-L-thyronine 5817-39-0 50mg
33p5p-Triiodo-L-thyronine (CAS 5817-39-0) is a thyroid hormone metabolite that acts primarily in the cytoplasm by activating a truncated thyroid receptor form (TR 1) which lacks nuclear localization capability It modulates cytoplasmic thyroid hormone receptor pathways and contributes to actin filament polymerization in neuronal and astrocytic cell populations 33p5p-Triiodo-L-thyronine exhibits its biological effects through non-classical signaling mechanisms In primary cultures of neuronal and astrocytic models it induces cytoskeletal remodeling events such as actin polymerization Based on these pharmacological properties 33p5p-Triiodo-L-thyronine serves as a research tool in neuroscience and endocrine studies focused on cytoplasmic thyroid hormone signaling and cellular morphology